CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence-Reference-Cited by-同舟云学术

CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence

Published:2020-05-04 Issue:6 Volume:38 Page:1653-1663
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

da Silva Elisa Feller Gonçalves,Lima Kelly Goulart,Krause Gabriele Catyana,Haute Gabriela Viegas,Pedrazza Leonardo,Catarina Anderson Velasque,Gassen Rodrigo Benedetti,de Souza Basso Bruno,Dias Henrique Bregolin,Luft Carolina,Garcia Maria Claudia Rosa,Costa Bruna Pasqualotto,Antunes Géssica Luana,Basso Luiz Augusto,Donadio Márcio Vinícius Fagundes,Machado Pablo,de Oliveira Jarbas Rodrigues

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-020-00941-2.pdf

Reference36 articles.

1. Yang JD, Hainaut P, Gores GJ et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. https://doi.org/10.1038/s41575-019-0186-y

2. Sachdeva M (2015) Immunology of hepatocellular carcinoma. World J Hepatol 7:2080. https://doi.org/10.4254/wjh.v7.i17.2080

3. Attwa MH (2015) Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol 7:1632. doi:https://doi.org/10.4254/wjh.v7.i12.1632